Veeva Oncology Link helps medical and commercial teams build stronger
relationships with experts across the global oncology community
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva
Systems (NYSE: VEEV) today announced Veeva
Oncology Link, an enterprise data solution to centralize insights
and intelligence on scientific leaders in oncology. Veeva Oncology Link
consolidates thousands of global experts and millions of activities,
including publications, clinical trials, and events, in a single,
complete source of oncology data. Now medical affairs and commercial
organizations can better plan and engage top industry thought leaders
and create deeper relationships with the global oncology community.
Oncology is one of the largest, most diverse, and fastest-growing
specialty areas in life sciences, and the ecosystem of oncology experts
is equally large and complex. Information about key scientific leaders
is typically managed in disparate data sources that quickly become out
of date. This makes it difficult to gain an in-depth understanding of
oncology expert profiles and interests.
Veeva Oncology Link provides a single, global data source to bring
together unique insights on scientific leaders for the life sciences
industry. Companies can better identify and reach top scientists and
researchers that are key to the successful product development and
launching of new cancer treatments.
Rich, up-to-date profiles provide visibility into oncology experts’
interests, affiliations, publications, trial activity, and partnership
opportunities. Data is continually kept current by utilizing both data
science and a team of oncology specific Veeva data stewards.
“Building valued scientific partnerships with the right experts is key
to bringing oncology products to market effectively and improving
patient outcomes,” said Kilian Weiss, general manager of Veeva Oncology
Link. “Veeva Oncology Link provides critical market insights across all
major tumor types around the world so the industry can build stronger
relationships with the global oncology community.”
Veeva will host therapeutic area leaders and experts during the Oncology
Forum at the Veeva European Commercial and Medical Summit on Nov. 29,
2017 in Madrid. The Forum will feature industry leaders, including
Novartis, for an in-depth discussion on oncology innovation. For more
information, visit veeva.com/EuropeanSummit.
Veeva Oncology Link is planned for availability in the summer of 2018.
Additional Information
For more on Veeva Oncology Link, visit: veeva.com/OncologyLink
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 550 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended
July 31, 2017. This is available on the company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005412/en/
Source: Veeva Systems